BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 24085572)

  • 1. Treatment of refractory chronic urticaria: current and future therapeutic options.
    Asero R; Tedeschi A; Cugno M
    Am J Clin Dermatol; 2013 Dec; 14(6):481-8. PubMed ID: 24085572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.
    Zuberbier T
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):9-18. PubMed ID: 21797930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts.
    Ferrer M; Jáuregui I; Bartra J; Dávila I; del Cuvillo A; Montoro J; Mullol J; Valero A; Sastre J
    Br J Dermatol; 2009 Apr; 160(4):823-7. PubMed ID: 19120332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Refractory Chronic Urticaria.
    Mehta A; Godse K; Patil S; Nadkarni N; Gautam M
    Indian J Dermatol; 2015; 60(3):230-7. PubMed ID: 26120147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative agents in refractory chronic urticaria: evidence and considerations on their selection and use.
    Khan DA
    J Allergy Clin Immunol Pract; 2013; 1(5):433-440.e1. PubMed ID: 24565613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Argentine guidelines for urticaria and angioedema].
    Máspero J; Cabrera H; Ardusso L; De Gennaro M; Fernández Bussy R; Galimany J; Galimberti D; Label M; La Forgia M; Medina I; Neffen H; Troielli P; ;
    Medicina (B Aires); 2014; 74 Suppl 1():1-53. PubMed ID: 25202880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-generation H1-antihistamines in chronic urticaria: an evidence-based review.
    Kavosh ER; Khan DA
    Am J Clin Dermatol; 2011 Dec; 12(6):361-76. PubMed ID: 21967114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihistamines in the treatment of chronic urticaria.
    Jáuregui I; Ferrer M; Montoro J; Dávila I; Bartra J; del Cuvillo A; Mullol J; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2007; 17 Suppl 2():41-52. PubMed ID: 18228682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic idiopathic urticaria unresponsive to type 1 antihistamines in monotherapy].
    Mateus C
    Ann Dermatol Venereol; 2003 May; 130 Spec No 1():1S129-44. PubMed ID: 12843818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria.
    Ayse Ornek S; Orcen C; Church MK; Kocaturk E
    Int Immunopharmacol; 2022 Nov; 112():109198. PubMed ID: 36115277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing?
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    J Investig Allergol Clin Immunol; 2013; 23(3):141-4; quiz 2 p preceding 145. PubMed ID: 23967751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features.
    Criado RF; Criado PR; Martins JE; Valente NY; Michalany NS; Vasconcellos C
    J Dermatolog Treat; 2008; 19(2):92-6. PubMed ID: 18484427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic urticaria: a comparison of management guidelines.
    Ortonne JP
    Expert Opin Pharmacother; 2011 Dec; 12(17):2683-93. PubMed ID: 22035356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic urticaria: aetiology, management and current and future treatment options.
    Kozel MM; Sabroe RA
    Drugs; 2004; 64(22):2515-36. PubMed ID: 15516152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic urticaria: a role for newer immunomodulatory drugs?
    Tedeschi A; Airaghi L; Lorini M; Asero R
    Am J Clin Dermatol; 2003; 4(5):297-305. PubMed ID: 12688835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Chronic Spontaneous Urticaria in Routine Clinical Practice Following the EAACI/GA(2)LEN/EDF/WAO Guidelines.
    Marín-Cabañas I; Berbegal-de Gracia L; de León-Marrero F; Hispán P; Silvestre JF
    Actas Dermosifiliogr; 2017 May; 108(4):346-353. PubMed ID: 28219634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamine.
    Curto-Barredo L; Giménez-Arnau AM
    G Ital Dermatol Venereol; 2019 Aug; 154(4):444-456. PubMed ID: 30717573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic alternatives for antihistamine-refractory urticaria].
    Maurer M; Altrichter S; Ardelean E; Krause K; Magerl M; Metz M; Siebenhaar F; Weller K; Zuberbier T
    Hautarzt; 2010 Sep; 61(9):765-9. PubMed ID: 20711555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation and treatment of chronic urticaria.
    Fonacier L; Aquino M; Kim B
    Postgrad Med; 2010 Mar; 122(2):148-56. PubMed ID: 20203466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria.
    Maurer M; Magerl M; Metz M; Zuberbier T
    J Dtsch Dermatol Ges; 2013 Oct; 11(10):971-7; quiz 978. PubMed ID: 24034140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.